annexure-i list of products sr. name of product quantity...
TRANSCRIPT
Aventon Pharmalabs 1
Annexure-I
List of Products
Sr.
No.
Name of product Quantity
MT/Month
1 Pregabalin 2
2 Telmisartan
3 Ondansetron HCl
4 Bupropioon hydrochloride
5 Celecoxib
6 Febuxostat
7 Lidocaine base/HCl 25
8 Diclofenac sodium / potassium/ diethylamine
9 Aceclofenac
Total 27
List of Raw Materials
Sr.
No.
Name of Raw Materials Quantity
(MT/MT)
1. Pregabalin
Isoveraldehyde 1.200
Ethyl cyano acetate 1.560
Di-n-propyl amine 0.025
n-Hexane 0.092
Diethyl malonate 2.120
Urea 0.860
Sodium hydroxide 1.352
Activated charcoal 0.040
Chloroform 1.24
Methanol 0.244
R-(+I-(a)-phenyl ethyl amine 0.820
Hydrochloric acid 0.600
Liquid Bromine 0.980
Hyflow powder 0.012
Aventon Pharmalabs 2
Sr.
No.
Name of Raw Materials Quantity
(MT/MT)
2. Telmisartan
Bibenzimidazole 0.840
Bromo methyl ester 0.848
Sodium hydroxide 0.160
Dimethyl Formamide 0.220
Acetone 0.068
Potassium hydroxide 0.340
Acetic acid 2.120
Methanol 0.720
Activated carbon 0.060
Celite 0.040
3. Ondansetron HCl
1,2,3,9-tetrahydro-4H-carbozole-4-one 0.920
Methylene dichloride 1.70
Sodium hydroxide 0.180
Dimethyl formamide 0.360
Tarta butyl ammonium bromide 0.004
Morpholine 0.080
p-formaldehyde 0.140
Toluene 0.920
2-methyl imidazole 0.360
Isopropyl alcohol 1.920
Hydrochloric acid 0.340
Activated charcoal 0.020
Hyflow powder 0.004
4. Bupropioon hydrochloride
3 Chloropropiopenon 0.020
Bromine 0.004
Isopropyl Alcohol HCl 0.060
Sodium Chloride 0.700
Aventon Pharmalabs 3
Sr.
No.
Name of Raw Materials Quantity
(MT/MT)
Sodium Thiosulphate 0.960
T-Butyl Amine 0.060
Toluene 0.200
Methanol 0.140
Activated Carbon 3.340
Celite 3.000
IPA 0.140
5. Celecoxib
4-Methyl acetophenone 0.260
Sodium methoxide 0.360
Ethyl triflouroacetate 0.620
Hydrochloric acid 0.840
Toluene 0.780
Isopropyl alcohol 0.100
4-Hydrozino benzene sulfonamide HCl 1.000
Methanol 0.160
Carbon 0.012
Celite 0.040
6. Febuxostat
Ethyl cyano methyl thio 1.180
NaOH 0.180
HCl 0.480
IPA 0.180
Acetone 0.300
Activated Carbon 0.060
Celite 0.040
7. Lidocaine base/HCl
2,6 Xylidine 0.330
Chloro acetyl chloride 0.435
k2CO3 0.490
Aventon Pharmalabs 4
Sr.
No.
Name of Raw Materials Quantity
(MT/MT)
Acetone 0.130
Diethyl Amine 0.440
NaOH 0.100
HCl 1.000
Carbon 0.010
Celite 0.005
8. Diclofenac sodium / potassium/ diethylamine
2,6 Dichloro sodium phenol 0.605
Potassium carbonate 0.275
Mono methyl chloro acethyl 0.440
Toluene 0.020
Aniline 0.350
Sodium methoxide 0.155
Chloro acethyl chloride 0.405
AlCl3 0.710
NaOH 0.250
Activated Charcoal 0.007
9. Aceclofenac
Chloro acetyl chloride 0.695
T-Butanol 0.332
N N Di methyl aniline 0.070
HCl 0.120
Soda ash 0.045
Diclofenac sodium 2.215
Toluene 0.090
Activated Carbon 0.025
Celite 0.003
NaOH 0.280
Aventon Pharmalabs 5
Annexure-II
Manufacturing Process, chemical reaction & Mass Balance
1. Pregabalin
Manufacturing Process:
Ethyl cyano acetate was first condensed with isoveraldehyde to give the
unsaturated ester micheak addition of diethyl malonate followed by acid-
induced decarboxylation gave glutaric acid which was then converted to
the amide acid via the anhydride intermediate.
Acid can be resolved with (R) - methyl benzyl amine to give the chiral
acid in 98%. Hoffmann reaction rearrangement of amide gave Pregabalin
in good yield.
Chemical reaction:
Aventon Pharmalabs 6
Aventon Pharmalabs 7
Aventon Pharmalabs 8
Mass balance:
Aventon Pharmalabs 9
IN PUT Kg Kg OUT PUT
Isoveraldehyde 300 427 Hexane recovery
Ethyl cyano acetate 390 25 Di-n-propyl amine
Di-n-propyl amine 25 60 Effluent (ML)
n-Hexane 450 138 Residue
515 Stage-1A Mass
Diethyl malonate 530 144 CO2
188 Effluent (ML)
172 Residue
541 Stage-1B Mass
Urea 215 163 CO2 & NH3 to scrubber
Sodium hydroxide 45 817 Effluent (ML)
Water 750 5 Residue
Activated charcoal 5
571 Stage-1C Mass
Chloroform 5100 4790 Chloroform recovery
Methanol 61 678 Residue
R-(+I-(a)-phenyl ethyl amine 205
469 Stage-II Mass
Hydrochloric acid 150 723 Effluent (ML)
Water 300
Sodium hydroxide 170
366 Stage-III Mass
Liquid Bromine 245
Sodium hydroxide 123 65 CO2
Activated charcoal 5 601 Effluent (ML)
Hyflow powder 3
Water 300
126 Drying Loss
250 Pregabalin-Product
Total 9372 9372
Dryer
Stage-3 Condensation
Hydrolysis
Stage-4 Condensation
& filteration
Mass balance of Pregabalin
Stage-1 A
Condensation
Hydrolysis
Stage-1 B
Condensation
Hydrolysis
Stage-1 C Condensation
Hydrolysis
Stage-2 Condensation
Hydrolysis
2. Telmisartan
Manufacturing Process:
Bibenzimidazole & bromomethyl ester is condensed in presence of sodium
methoxide in DMF to give Telmi-I (Methyl 4’-[[4-Methyl-1H benzimidazol-
2-yl)-2-propyl-1H-benzimidazole-1-yl] methyl] biphenyl 2-carboxylate).
Telmi-I is hydrolyzed using potassium hydroxide in methanol & water
mixture to give Telmisartan.
Chemical reaction:
Stage I- Preparation of Telmi-I
Aventon Pharmalabs 10
Stage II
Aventon Pharmalabs 11
Mass balance:
IN PUT Kg Kg OUT PUT
Bibenzimidazole 210 1035 Dimethyl formamide
Bromo methyl ester 212 315 Acetone
Sodium hydroxide 40 170 Organic Residue
Dimethyl formamide 1090 1480 Effluent (ML)
Acetone 332
Water 1340
294 Rection mass
Potassium hydroxide 85
Acetic acid 530 3540 Methanol
Methanol 3720 225 Residue
Activated carbon 15 2755 Effluent (ML)
Celite 10 35 Spent carbon
Water 2305
84 Drying Loss
250 Telmisartan-Product
Total 9889 9889
Mass balance of Telmisartan
Stage-I Reaction
Stage-2 Reaction &
filteration
Dryer
Aventon Pharmalabs 12
3. Ondansetron HCl
Manufacturing Process:
1,2,3,9-tetrahydro-4H-carbazole is reacted with 2-methyl imidazole in
presence of hydrochloric acid and isopropyl alcohol to obtain Ondansetron
hydrochloride.
Chemical reaction:
Mass balance:
Aventon Pharmalabs 13
IN PUT Kg Kg OUT PUT
1145 Methylene dichloride recovery
630 Effluent (ML)
Methylene dichloride 1570 75 Residue
Sodium hydroxide 45
Water 120
Dimethyl formamide 90
Tarta butyl ammonium bromide 1
206 Stage I Mass
Morpholine 20 915 Toluene Recovery
p-formaldehyde 35 425 Effluent (ML)
Toluene 1145 120 Residue
2-methyl imidazole 90
Water 215
251 Stage II Mass
Isopropyl alcohol 1215 735 Isopropyl alcohol recovery
Water 965 1317 Effluent (ML)
Hydrochloric acid 85 10 Used carbon
Activated charcoal 5 130 Residue
Hyflow powder 1
80 Drying Loss
250 Ondansetron HCl - Product
Total 5832 5832
Dryer
Stage-III
Purification/Cry
stallization/
centrifuge
Mass balance of Ondansetron HCl
Stage-I
Methylation
Stage-II Manichh
Reaction
1,2,3,9-tetrahydro-4H-carbozole-4-
one230
4. Bupropioon hydrochloride
Manufacturing Process:
Stage-1
3΄Chloropropiophenone and Bromine are reacted in water as a solvent
media and progress of the reaction is monitored on HPLC.
After the completion of the reaction the mass is treated with sodium
Thiosulphate solution and the subjected to work up. The organic layer
containing product is then again reacted with tertiary butyl amine and
again the reaction is monitored on HPLC.
After the completion of reaction excess of the tertiary butyl amine is
distilled off and the residual mass is then washed with water, precipitated
with IPA HCL and centrifuged.
This is stage-1 which is further used after analysis.
Stage-2
Bupropion Hydrochloride Stage-I is dissolved in methanol, purified by
means of Charcoalisation followed by filtration & finally crystallized in
Isopropanol to yield pure Bupropion Hydrochloride.
Chemical reaction:
Aventon Pharmalabs 14
Mass balance:
IN PUT Kg Kg OUT PUT
3 Chloropropiopenon 170 350 T-Butyl Amine Recovery
Bromine 175 1020 Mixture of IPA & Toluene
Water 1680 1874 Effluent (ML)
Isopropyl Alcohol HCl 240 95 Residue
Sodium Chloride 170
Sodium Thiosulphate 15
T-Butyl Amine 365Toluene 835
311 Bupropion HCl Stage-1
Methanol 750 715 Methanol recovery
Activated Carbon 15 35 Carbon + Celite
Celite 4 715 Iso Propyl Alcohol Recovery
IPA 750 65 Residue
50 Drying Loss
250 Bupropion Hydrochloride
Total 5169 5169
Mass balance of Bupropion Hydrochloride
Bromination
Filteration
Dryer
5. Celecoxib
Manufacturing Process:
Cele-1 is prepared from 4-Methyl acetophenone and ethyltrifluoroacetate
in toluene using sodium methoxide as a base. To slurry of sodium
methoxide in toluene 4-Methyl acetophenone is added slowly and stirred.
Then ethyltrifluroacetate is added slowly.
Reaction mass is heated and stirred to complete the reaction. After
completion of reaction, reaction is cooled and quenched with water. pH is
Aventon Pharmalabs 15
made acidic by adding concentrated HCl and product is extracted in
toluene.
Toluene layer is concentration to give oil, which is taken in isopropanol,
and water is added to obtain Cele-1 in solid form. Cele-1 is filtrated
washed with water and dried.
Cele-1 and 4-Hydrazino benzene sulfonamide HCl are taken in ethanol
and refluxed. After completion of reaction, reaction mass is cooled and
filtered to remove excess unreacted 4-Hydrazino benzene sulfonamide.
Water is added to ethanol filtrate to precipitate the product. Product is
filtrated and dried to get Celecoxib Crude.
Celecoxib pure is obtained from Celecoxib crude by crystallization in
toluene. Celecoxib crude is dissolved in toluene and charcolized with
activated carbon. Then reaction mass is cooled and ethanol is added to it.
Reaction mass is filtered through celite bed followed by filtration.
Filtrate is heated to distill out ethanol. The reaction mass is cooled and
stirred. Product is filtrated and wet solid is again crystallized with toluene
to give pure Celecoxib.
Chemical reaction:
Step I= Preparation of Cele-1:
Step-II= Preparation of Celecoxib crude:
Step-III= Preparation of Celecoxib:
Aventon Pharmalabs 16
Mass balance:
IN PUT Kg Kg OUT PUT
4-Methyl acetophenone 140
Sodium methoxide 90
Ethyl triflouroacetate 205 1410 Effluent (ML)
Hydrochloric acid 210
Toluene 425
Isopropyl alcohol 430
Water 1140
175 Celecoxib-I4-Hydrozino benzene sulfonamide HCl 250 1630 Effluent (ML)
Water 1482 885 Methanol
Methanol 925
317 Celecoxib crude
Carbon 3 20 Spent Carbon + Celite
Celite 10 710 Toluene
Toluene 745 55 Residue
40 Drying Loss
250 Celecoxib-Product
Total 6055 6055
Dryer
Mass balance of Celecoxib
Reaction
Reaction
Filteration
Mixture of solvent (IPA, Toluene,
Ethanol, Methanol)1055
6. Febuxostat
Manufacturing Process:
Ethyl-2(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate
(NV07-3) is hydrolyzed with sodium hydroxide solution in isopropyl
alcohol to furnish the product. The pH is adjusted with hydrochloric acid
and solid is separated by filtration as Febuxostat crude.
Febuxostat (crude) is dissolved in acetone and charcoalized. After
filtration, acetone is distilled out and solid is filtered to give Febuxostat.
Chemical reaction:
Stage I-Preparation of Febuxosfat Crude:-
Aventon Pharmalabs 17
Stage II - Purification of Febuxostat:-
Mass balance:
IN PUT Kg Kg OUT PUT
Ethyl cyano methyl thio 295 835 IPA
NaOH 45 45 Residue
HCl 120 3055 Effluent (ML)
IPA 880
Water 2900
305 Febuxostate crude
Acetone 1245 1170 Acetone
Activated Carbon 15 40 Spent Carbon + Celite
Celite 10 60 Residue
55 Drying Loss
250 Febuxostate
Total 5510 5510
Mass balance of Febuxostate
Hydrolysis
Purification
Dryer
7. Lidocaine base/HCl
Manufacturing Process:
2,6-Xylidine is reacted with CAC in the presence of acetone to get Chloro
acetamides.
CAX is reacted with Diethylamine in presence of NaoH with exotherm to
get Lidocain Base.
Lidocine base is purified with Activated charcoal in the presence of
Toluene.
Aventon Pharmalabs 18
Lidocain base is reacted with HCl in acetone to get Lidocaine HCl.
Chemical reaction:
CH3
NH2
CH3
+ C2H
2Cl
2O
CH3
CH3
NHCOCH2Cl
+ HCl
2,6-Xylidine
121.2 gm/Mol 112.94 gm/Mol
N-Chloroacetyl 2,6-Xylidine (CAX)
197.5 gm/Mol
36.5 gm/Mol
NHCOCH2Cl
CH3
CH3
(CAX)
197.5 gm/Mol
+ 1/2 C
4H
11N
DEA
73.14 gm/Mol
CH3
CH3
NH
Lidocine Base C14
H22
N2O
234.34 gm/Mol
IPA HCl
CH3
NH
CH3
Lidocine HCl
C14
H22
N2O.HCl.H
2O
288.81 gm/Mol
O
NCH
3
CH3
N
CH3
CH3
O. HCl. H
2O
Mass balance:
Aventon Pharmalabs 19
IN PUT Kg Kg OUT PUT
2,6 Xylidine 330 2730 Effluent (ML)
Chloro acethyl Chloride 435 470 Acetone
K2CO3 490 45 Residue
Acetone 495
Water 1985
490 Chloro Acetamide
Diethyl Amine 1710 1270 Diethyl Amine
Water 980 860 Effluent (ML)
NaOH 100
1150 Lidocaine Base Crude
Acetone 2000 1895 Acetone
HCl 1000 775 Effluent (ML)
Carbon 10 25 Carbon + Celite
Celite 5 125 Residue
345 Drying Loss
1000 Lidocaine Base/ HCl
Total 9540 9540
Reaction-3
Mass balance of Lidocaine Base/HCl
Reaction-1
Reaction-2
Dryer
8. Diclofenac sodium / potassium/ Diethylamine
Manufacturing Process:
2,6-Diclorophenol is dehydrated by using Potsaaium Carbonate in the
presence of Toluene then reacted with MMCA and SMO in presence of
Aniline.
2, 6-Dichlorophenylamine is dehydrated in Toluene then reacted with CAC
to get N-Choloroacetyl 2,6-dichlorophenyl. N-Chloroacetyl 2,6-
dichlorophenyl is heated in the presence of catalyst AICI3 and quenched
to get N-chlorophenyl Indolinone.
N-chlorophenyl Indolinone is hydrolyzed by NAOH/KOH to get crude
Diclofenac Sodium or Potassium.
Diclofenac crude is purified by activated carbon and crystallized to get
pure Diclofenac.
Diclofenac pure is acidify with Acetic acid then reacted with Diethylamine
in presence of Acetone to give Diclofenac Diethylmine.
Chemical reaction:
Aventon Pharmalabs 20
Aventon Pharmalabs 21
Mass balance:
IN PUT Kg Kg OUT PUT
2,6 Dichloro sodium phenol 605 70 CO2
Potassium carbonate 275 385 Toluene Recover
Mono methyl chloro acethyl 440 22 Residue
Toluene 405 865 Effluent (ML)
Water 790
823 2,6 Dichloro Phenoxy Ethyle
Aniline 350 225 Effluent (ML)
Sodium methoxide 155
833 Chloro diphenyl amine
Chloro acethyl chloride 405 105 HCl gas
1133 N chloro acethyl dichloro diphenyl amine
AlCl3 710
NaOH 250 2790 ML of AlCl3
Activated Charcoal 7 3340 Effluent (ML)
Water 4215
Ice 625
430 Drying loss
1000 Diclofenac Sodium-Product
Total 9232 9232
Dryer
Mass balance of Diclofenac Sodium
Reaction-1
Reaction-2
Reaction-3
Reaction-4
9. Aceclofenac
Manufacturing Process:
The mixture of N, N Dimethyl Aniline and t-Butanol is reacted with Chloro
acetyl chloride in controlled temperature followed by Hydrochloric acid
and Soda Ash wash.
Distilled out the product to get the T-Butyl Chloro Acetate.
Aventon Pharmalabs 22
T-Butyl Chloro Acetate is reacted with Diclofenac Sodium in presence of
TBAB followed by Formic acid give the Aceclofenac Crude.
Aceclofenac crude is purified with activated carbon in the presence of
Toluene.
Chemical reaction:
Aventon Pharmalabs 23
Aventon Pharmalabs 24
Aventon Pharmalabs 25
Mass balance:
Aventon Pharmalabs 26
IN PUT Kg Kg OUT PUT
Chloro acetyl chloride 695 1095 N.N. Dimethylaniline HCl
T-Butanol 495 2025 Effluent (ML)
N N Di methyl aniline 805
HCl 120
Soda ash 45
Water 2010
1045 T-Butyl Chloro Acetate
Diclofenac sodium 2215 1650 Toluene
Toluene 1740 70 Distillation Residue
Water 2045 1460 Process Residue
2430 Effluent (ML)
1420 Aceclofenac Crude
Formic acid 1530 163 T-Butanol
Water 60 35 Used carbon + celite
Activated Carbon 25 1530 Formic acid
Celite 3
330 Drying loss
1000 Aceclofenac-Product
Total 11788 11788
N.N. Dimethylaniline HCl 1095 735 N,N dimethylbenzeneamine
NaOH 280 795 Effluent (ML)
Water 155
Total 1530 1530
Mass balance of Acectofenac
Reaction vessel
Filtration
Purification
N,N dimethyl
amine recovery
Dryer
Aventon Pharmalabs 27
Annexure-III
Water consumption & wastewater generation
Sr.
No.
Name of Product Water
Consumption Lit/Day
W/W
Generation
Lit/Day
1. Pregabalin 432 764
Telmisartan 1166 1355
Ondansetron HCl 416 759
Bupropioon hydrochloride 537 599
Celecoxib 839 972
Febuxostat 928 977
2. Lidocaine base/HCl 2965 4365
Diclofenac sodium / potassium/
diethylamine
5630 4430
Aceclofenac 4270 5250
Sr.
No.
Break up Water
Consumption
Lit/Day
w/w
Generation
Lit/Day
I Domestic 2000 1700
II Gardening 7500 -
III Industrial
(a) Process 6800 6600
(b) Scrubber 1000 1000
(c) Washing 4000 4000
(d) Cooling 8000 2500
(e) Boiler 5000 500
(f) Water treatment 2000 2000
Total Industrial 26800 16600
Total (I + II + III) 36300 18300
Less Recycle 16000 -
Actual fresh water
requirements
20300 --
Aventon Pharmalabs 28
Annexure-IV
Details of Air Emission
Sr.
No.
Stack attached
to
Stack
Height
in m
Fuel
Used
Fuel
consumption
rate
APC
measure
Pollutant
1 Steam Boiler (2
T/hr)
21 Agro
waste
6.0 TPD Cyclone
followed by
bag-filter
PM<150 mg/NM3
SO2<100 ppm
NOx<50 ppm 2 Thermic fluid
heater (2 lac
Kcal/hr)
Agro
waste
1.5 TPD
3 DG Set (100 kVA) 11 HSD 30 lit/hr --
Aventon Pharmalabs 29
Annexure-V
Details of Hazardous Generation and Disposal
Sr.
No.
Type of
Solid Waste
Schedule Quantity
MTPM
Disposal method
1 ETP Waste
MEE Salt
34.3 10.000
3.125
13.125
Collection, storage & disposal at
TSDF site approved by GPCB.
2 Process/
distillation
residue
29.1 /
20.3
30
MT/month
Collection, storage & disposal at
CHWIF or co-processing.
3 Used
Lubricating
Oil
5.1 0.2 Kl/year Collection, storage & use within
premises as lubricant/sell to
registered recycler.
4 Discarded
containers/
barrels/
liners
33.3 Barrels-
1000
nos./month
Liner-100
kg/month
Collection, storage and reuse for
packing of products or disposal
by selling to approved recycler or
traders.